INTELLIGENCE IN ACTION

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

March 15, 2019

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show that demonstrated this impact through the lens of a very hot topic: prescription price transparency.

In true collaborative form, Dr. Steve Miller, Chief Clinical Officer of Cigna, and Dr. Troyen Brennan, Executive Vice President and Chief Medical Officer of CVS Health, joined Surescripts CEO Tom Skelton on stage for Views from the Top: Price Transparency in Prescription Drug Costs.




Check out the highlights video, which details:

  1. Why patients give up on their meds: Many patients choose to abandon treatment, due to delays that result from additional administrative work associated with their prescription, or out-of-pocket cost.


  2. The “horrible experience” that makes patients question their healthcare choices: Dr. Miller self-admittedly shares that doctors are too busy “making love to their keyboard” to truly connect with patients and provide high-quality care.


  3. How a little retail therapy might help: A more consumer-centric approach that mimics other positive online shopping experiences can empower patients and help inform their healthcare buying decisions.


  4. The real-time tool trio that’s changing the game: Three key technologies that, when combined, create a dramatically improved consumer experience—without unnecessary headaches at the pharmacy.


  5. And the mountain of money we can save: In addition to improved quality and safety, find out just how much money we can save every year by deploying these technologies at the point of care.

As our experts shared, the tools that will revolutionize patient-provider interaction are available today. Watch the full-length video to learn more. 

Related Articles

June 19, 2019

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

Anyone who works in health IT knows how gratifying it is when we offer clinicians a tool that is so much better than old processes, and they run with it. And it’s especially transformative when technology replaces a manual process—one that absorbed a great deal of time and resources.  Read more...
May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX